KHKristina Herzog

Kristina Herzog

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kristina Herzog has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    “MyLogbook—I Know My Way Around”: A Psychological Therapy Program to Enhance Health Literacy and Positive Emotional Adjustment in Pediatric Oncology

    by Liesa J. Weiler‐Wichtl, Verena Fohn‐Erhold, Verena Rosenmayr, Rita Hansl, Maximilian Hopfgartner, Jonathan Fries, Carina Schneider, Kristina Herzog, Kirsten Neumann, Tobias Schellenberg, et al.

    Background: Severe and chronic illnesses such as an oncological disease in children, adolescents, and young adults (CAYAs) are accompanied by profound physical, psychological, and social challenges for the patients and their families. Consensus‐ and evidence‐based psychosocial standards of care aim to address these challenges but implementation is heterogeneous. The current paper presents the consensus‐ and evidence‐based psychosocial therapy tool “MyLogbook—I know my way around” which aims to operationalize and implement existing guidelines for psychosocial care in pediatric oncology, supporting patients from diagnosis through follow‐up care with psychoeducational and emotional resources. Procedure: This multi‐center pilot study evaluated the feasibility and efficacy of “MyLogbook” in 240 participants (mean age = 9.00, SD = 2.78; 50.8% female) across 22 pediatric oncology treatment centers and rehabilitation centers in Germany, Austria, Switzerland, and Italy. The therapy program involves psychoeducational modules tailored to different medical treatment phases and includes assessments of emotional well‐being and health literacy. Psychosocial health care professionals (HCPs) of the respective center conducted selected modules with children, with each module consisting of two 60‐min sessions. Efficacy was determined through pre‐ and post‐session assessments of children's emotional states with validated measures and their self‐perceived, module‐specific expertise (health literacy) on a scale of [1;5]. Results: A significant improvement in subjective module‐specific health literacy was observed, with self‐reported expertise increasing from a mean of 2.97 (SD = 1.45) following session 1 to 3.97 (SD = 1.13) following session 2 (Wilcoxon V = 1597.5, p < 0.001). Negative emotions significantly decreased across sessions ( B = −0.342, p < 0.001), as did neutral emotions ( beta = −0.194, p < 0.001), whereas positive emotions significantly increased ( beta = 0.051, p = 0.011). Notably, 38% of children and 40% of parents reported average QoL at baseline, which had no impact on the outcome of emotional well‐being over time. The highest efficacy of the therapy program “MyLogbook” was observed in psychoeducational modules addressing early treatment phases (e.g., more than half of used booklets are accounted for by “Everything there is to know!”, “My path to diagnosis” and “I’M Ready”). Conclusion: The psychological therapy program “MyLogbook” effectively translates psychosocial care guidelines into clinical practice, improving emotional well‐being and health literacy among pediatric oncology patients and their families. To maximize its impact, future efforts should address structural challenges, integrate modules into a unified format, and expand accessibility through multi‐lingual adaptations. This published psychosocial therapy program demonstrates the feasibility of delivering standardized psychosocial interventions and highlights their potential to enhance the quality of life for young patients with cancer. Trial Registration: ClinicalTrials.gov Identifier: NCT04474678

  • Open Access

    An intervention for fear of progression in childhood cancer patients and their parents: feasibility and preliminary efficacy in a pilot randomised controlled trial

    by Jessy Herrmann, Laura Kern, Anja Santel, Kristina Herzog, Leonard Konstantin Kulisch, Christa Engelhardt-Lohrke, Rahel Hoffmann, Christiane Chen-Santel, Jörn-Sven Kühl, Florian Schepper

    Background: Fear of progression (FoP) is a significant psychosocial burden for children with cancer and their parents, influencing their quality of life (HRQoL) and emotional adjustment. In this pilot randomised controlled trial (RCT) we present results on feasibility and preliminary efficacy of the family-based therapeutic intervention “Kinder-Progredienzangst” (KIPA), targeting FoP in pediatric oncology. Methods: N = 29 families with a child undergoing acute cancer treatment or follow-up care completed the program, with participation open to parents alone or to parents and children; ultimately, n = 6 children participated. Eligibility criteria included moderate or high FoP in at least one family member. Families were randomised to either an intervention group or a waitlist-control group receiving treatment as usual. KIPA consists of psychoeducation, anxiety confrontation, and resource activation. Participants completed questionnaires for FoP, anxiety, depression, HRQoL, and posttraumatic stress symptoms (PTSS) at different time points. Participation and retention rates were calculated, and we used Mann-Whitney U tests for between-group comparisons, Friedman and Wilcoxon tests for within-group comparisons and Hedges g for effect sizes. Results: Feasibility results showed a participation rate of 23%, with higher participation in acute treatment (51%) compared to follow-up care (15%). Retention rates were 71% overall, with significant variability between settings. Efficacy analyses revealed significant differences in parental FoP between study conditions with high effect size ( W = 65.5, p =.023, g =-0.855). Improvements were also noted in PTSS ( W = 33, p <.001, g =-1.365), anxiety ( W = 59, p =.017, g =-0.906) and mental ( W = 217, p <.001, g = 1.619) and physical ( W = 180, p =.042, g = 0.834) HRQoL. The pre-post analysis showed a significant reduction in parental FoP in both settings, and the follow-up data indicates sustainability. Effects on children’s FoP were not significant. Conclusion: The study showed mixed feasibility—particularly regarding child participation, follow-up enrolment and drop-out during acute treatment—highlighting the need for optimisation before larger trials. Nevertheless, the data provide initial indications that KIPA may benefit parents of children with cancer across both acute and follow-up care settings, a group highly affected by FoP. Given the methodological limitations, the efficacy results should be viewed as preliminary. To demonstrate KIPA’s effectiveness, especially in children, large multicentre trials using reliable RCT designs suitable for acute care settings are needed. Trial registration: The trial was retrospectively registered at the German Trial Registry (TRN: DRKS00024106, 04.05.2022).

  • Open Access

    Fear of Progression in Pediatric Cancer Patients and Their Parents: Trajectories, Prevalence, and Correlates Across Acute Treatment and Follow‐Up Care

    by Jessy Herrmann, Kristina Herzog, Julia Martini, Anja Santel, Leonard Konstantin Kulisch, Jörn‐Sven Kühl, Florian Schepper

    Purpose: Fear of progression (FoP) represents a significant psychological burden for pediatric cancer patients and their parents. This study investigates FoP levels across acute treatment (AcT) and follow‐up care (FuC) and examines trajectories over time, associated sociodemographic factors, and parent‐child associations. It also proposes clinically relevant thresholds for psychosocial care. Methods: A total of 171 patient–parent dyads participated in a cross‐sectional and longitudinal study. Children aged 7–18 and one parent per child completed the Fear of Progression Questionnaire—Short Form (FoP‐Q‐SF). Data were collected during AcT (two time points) and FuC. Statistical analyses included nonparametric tests and correlation analyses. Results: FoP levels were significantly lower during FuC compared to AcT for both children and parents, and parental FoP decreased over the 1‐year follow‐up period. Parents consistently showed higher FoP than their children, and a significant parent–child correlation emerged in FuC. FoP was higher in girls and was positively associated with child age and negatively associated with parent age. Using suggested thresholds, 57.8% of parents showed dysfunctional FoP. Among children, 45.2% reported low, 40% moderate, and 14.8% high FoP. Conclusion: Although levels of FoP are lower in FuC than in AcT, they remain a prevalent burden—particularly for younger parents, older children, and girls. The observed parent‐child associations highlight the need for family‐oriented psychosocial care. A proposed three‐stage cut‐off (low, moderate, high FoP) may guide clinical decision‐making and support tailored treatment strategies. Routine screening and preventive approaches are recommended to mitigate FoP and its potential intergenerational transmission. Trial Registration: The study has been pre‐registered at the German Clinical Trials Register (DRKS 00022034, registered 29 th of June 2020) and at the Open Science Foundation ( https://osf.io/fuahc ).


  • Open Access

    Psychometric Properties of the Fear of Progression Questionnaire for Children in Two German Samples (Acute Treatment and Follow‐Up Care)

    by Florian Schepper, Anja Santel, Jessy Herrmann, Kristina Herzog, Leonard Konstantin Kulisch, Jörn‐Sven Kühl, Julia Martini

    Background: Fear of progression (FoP) is among the most prevalent psychosocial burdens in paediatric oncology. Empirical evidence suggests that FoP is particularly pronounced during acute treatment and often persists into follow‐up care. It is associated with heightened perception of physical symptoms, increased post‐traumatic stress symptoms, more negative illness perceptions, and reduced quality of life (QoL). Consequently, a comprehensive diagnostic instrument is essential to assess FoP in children with cancer. Objective: This study aimed to prospectively validate the German self‐report version of the Fear of Progression Questionnaire for Children (FoP‐Q‐SF/C) aged 7–18 years both during acute treatment and in follow‐up care. Methods: A total of 116 children participated in the study, including 39 undergoing acute treatment and 77 in follow‐up care. Participants completed the FoP‐Q‐SF/C. Factor analyses were conducted, and associations between FoP and QoL, illness perceptions, posttraumatic stress symptoms, time since diagnosis, cancer type and treatment modality were examined. Results: All items were applicable in children. The FoP‐Q‐SF/C demonstrated high internal consistency and good convergent, criterion and divergent validity. Consistent with previous research, factor analysis supported a one‐factor structure, although findings suggest potential for structural refinement. Conclusions: The FoP‐Q‐SF/C is a reliable and valid questionnaire for assessing FoP in children with cancer across different treatment phases. It serves as a valuable screening instrument to identify children at risk for elevated psychosocial distress and to guide targeted psychosocial interventions.


  • Open Access

    Trajectories of illness perceptions in paediatric cancer patients and their parents and associations with health‐related quality of life: Results of a prospective‐longitudinal study

    by Kristina Herzog, Florian Schepper, Remo Kamm‐Thonwart, Jessy Herrmann, Mihaela Budich, Liesa Weiler‐Wichtl, Thomas Pletschko, Meinolf Suttorp, Holger Christiansen, Julia Martini

    Objective: In paediatric oncology, little is known about trajectories of illness perceptions and their longitudinal associations with health‐related quality of life (HRQoL). Therefore, the aim of this study was to investigate changes in illness perceptions in children and parents over a one‐year‐period and to investigate predictive value of child's and parent's illness perceptions during acute treatment for child's HRQoL 1 year later.Methods: N = 65 child‐parent‐dyads participated in a longitudinal study (retention rate: 80.2%). Children were 4–18 years of age and underwent acute cancer treatment at baseline. Children and parents reported on their own illness perceptions (Illness‐Perception‐Questionnaire‐Revised), as well as on the child's HRQoL (KINDL‐R) at baseline and one‐year‐follow‐up. Paired‐samples t‐tests were calculated to investigate changes over time. A hierarchical multiple regression analysis was performed to investigate predictive value of child's and parent's illness perceptions for child's HRQoL.Results: Child's HRQoL t(63) = −6.73, p < 0.001, their perceptions of coherence (i.e. understanding; t(54) = −2.36, p = 0.022) and consequences of their illness (t(54) = 2.86, p = 0.006), and parent's perception of cyclical trajectory (t(61) = 2.06, p = 0.044) improved from baseline to 1‐year‐follow‐up. All other illness perceptions remained stable. Exploratory post‐hoc analyses showed differences in the pattern of change in age‐, gender‐, and diagnosis‐specific subgroups. After controlling for baseline levels of HRQoL, child's perceptions of symptoms and consequences were independent predictors of their HRQoL 1 year later (R2 = 0.396, F(2,52) = 10.782, p < 0.001), whereas no parent's illness perceptions added predictive value.Conclusion: In paediatrics, child's and parent's illness perceptions should be assessed. Our findings highlight the importance of illness perceptions as potential modifiable variables in interventions to improve child's HRQoL.


  • Open Access

    The puppet interview to measure illness perceptions in paediatric oncology: development and psychometric properties in acute treatment and follow-up care

    by Kristina Herzog, Florian Schepper, Jessy Herrmann, Julia Martini

    Background: Illness perceptions comprise assumptions about symptoms, timeline, consequences, controllability, and emotional responses to an illness. Recent evidence shows that illness perceptions are associated with coping and well-being. So far, assessment in paediatric care was based on parental report only, since no instrument for the direct assessment of young children was available. We aim to describe the development (incl. indication and contraindication) of an innovative puppet interview to assess illness perceptions in children with cancer from the age of four years. Moreover, we investigate longitudinal trajectories and examine psychometric properties. Methods: The puppet interview was developed based on the Illness-Perception-Questionnaire-Revised and the Berkeley-Puppet-Interview. Longitudinal trajectories and psychometric properties were examined in a sample of patient-parent dyads (N = 75) in a prospective longitudinal study in acute treatment with a 1-year follow-up (study 1: nT1 = 41, nT2 = 27) and in a cross-sectional study in follow-up care (study 2, n = 34). Results: The puppet interview is comprehensible and well-received by children in acute treatment and follow-up care. There were significant differences in perceptions of a chronic timeline (U = 301.00, p = .008), consequences (U = 251.00, p = .008), and emotional representations (U = 244.50, p = .020) between children in acute treatment and children in follow-up care. Over the course of one year, children in acute treatment perceived more symptoms as part of their illness (MT1 = 3.6, SDT1 = 2.9, MT2 = 4.5, SDT2 = 3.1, n = 27, Z = -2.603, p = .009). We found expected intercorrelations between illness perception dimensions, e.g. between perception of consequences and emotional representations (rτ = .27, p = .033), and between perception of a chronic timeline and consequences (rτ = .38, p = .001). Moreover, we found confirming results regarding construct validity, as child’s perceptions of symptoms correlated with their self-rated HRQoL (rτ = -.32, padj. = .014). Also parent-rated subscale on illness-specific aspects of child’s HRQoL correlated with child’s perception of symptoms (rτ = -.26, padj. = .016), cyclicity (rτ = -.28, padj. = .016), and consequences (rτ = -.34, padj. = .014). Acceptable internal consistency was shown for the dimensions timeline-acute/chronic and personal control. Conclusions: Parental report can now be complemented by a self-report of illness perceptions in children aged four years and older. This will allow for the further adaptation of medical and psychosocial care during and after acute cancer treatment. Trial registration: The study has been pre-registered at the German Clinical Trials Register (registered 30/06/2020; DRK-S00022034) and at the Open Science Foundation (https://osf.io/7xr6z).


  • Screening zur Einschätzung des psychosozialen Nachsorgebedarfs in der pädiatrischen Onkologie (NPO-11) für Selbst- und Elternbericht

    by Leonard Konstantin Kulisch, Jessy Herrmann, Kristina Herzog, Hagen Graf Einsiedel, Remo Kamm-Thonwart, Rahel Hoffmann, Yvonne Jäschke, Julia Martini, Florian Schepper

    Zusammenfassung: Hintergrund Krebserkrankungen bei Kindern sind mit einem erhöhten Risiko für psychosoziale Belastungen assoziiert. Zur quantitativen und qualitativen Bedarfseinschätzung nach psychosozialer Nachsorge liegen bisher keine Instrumente vor. Mit dem NPO-11 wurde nun ein ökonomisches Screening entwickelt. Patient:innen und Methoden 11 dichotome Items erfassen die Bereiche Progredienzangst, Traurigkeit, Antrieblosigkeit, Selbstwertprobleme, Schul- und Ausbildungsprobleme, somatische Beschwerden, emotionaler Rückzug, soziale Desintegration, Pseudoreife, Eltern-Kind-Konflikte sowie Elternpaar-Konflikte entweder im Selbst- oder Elternbericht. Zur psychometrischen Überprüfung wurde der NPO-11 an N=101 Eltern-Kind-Dyaden getestet. Ergebnisse Selbst- und Elternberichtversion zeigten eine gute Ausfüllgüte mit Zustimmungsraten ohne Boden- oder Deckeneffekte. Die Interrater-Reliabilität der 11 Items war ausreichend bis moderat. Faktorenanalytisch konnte die Gültigkeit eines Gesamtwerts nachgewiesen werden. Dieser zeigte für Selbst- und Elternbericht eine ausreichende bzw. gute interne Konsistenz sowie hohe Validität durch Korrelationen mit gesundheitsbezogener Lebensqualität. Schlussfolgerung Mit dem NPO-11 wurde ein reliables und valides Screening zur Einschätzung des psychosozialen Nachsorgebedarfs in der pädiatrischen Onkologie entwickelt. Bei dem Übergang von stationärer zu ambulanter Behandlung kann die Einschätzung zur Intensität notwendiger, psychosozialer Interventionen unterstützt sowie zugehörige Themenfelder identifiziert werden.


  • Open Access

    Illness perceptions, fear of progression and health-related quality of life during acute treatment and follow-up care in paediatric cancer patients and their parents: a cross-sectional study

    by Kristina Herzog, Florian Schepper, Thomas Pletschko, Jessy Herrmann, Mihaela Budich, Holger Christiansen, Meinolf Suttorp, Julia Martini

    Background: This study examines the role of illness perceptions and fear of progression (FoP) in paediatric cancer patients and their parents for patient’s health-related quality of life (HRQoL), controlling for sociodemographic and medical variables. 4–18-year-old patients in acute treatment or follow-up care and one parent were examined. Methods: N = 46 patient-parent dyads in acute treatment and n = 84 dyads in follow-up care completed measures on illness perceptions (Illness-Perceptions-Questionnaire for 12–18-year-old patients and parents or as age-adapted puppet interview for 4–11-year-old patients) and FoP (Fear-of-Progression-Questionnaire for 7–18-year-old patients and parents). Patients also completed the KINDL-R to measure HRQoL. Hierarchical multiple regression analyses were calculated. Results: In acute treatment, patient’s perceptions of symptoms and cyclicity of their illness explained variation in their HRQoL in addition to sociodemographic and medical variables. In follow-up care, patient’s FoP and parent’s perception of consequences explained additional variation in patient’s HRQoL. Overall, sociodemographic and medical variables explained less variation in HRQoL in follow-up care than in acute treatment. Conclusions: Our results stress the importance of psychological factors for the well-being of paediatric cancer patients, particularly in follow-up care, where sociodemographic and medical variables play a lesser role. We recommend screening for illness perceptions and FoP during and after acute treatment to support patients and parents. Furthermore, standardized interventions focussed on changing maladaptive illness perceptions should be developed and evaluated. As parents’ perceptions, thoughts, and feelings may also play an important role for the well-being of the patients, interventions should be family-focussed and include parents. Trial registration The study has been pre-registered at the German Clinical Trials Register (registered 30/06/2020; DRKS00022034) and at the Open Science Framework (https://osf.io/3uwrx).


  • Open Access

    Screening zur Einschätzung des psychosozialen Nachsorgebedarfs in der pädiatrischen Onkologie (NPO-11) für Selbst- und Elternbericht

    by Leonard Konstantin Kulisch, Jessy Herrmann, Kristina Herzog, Hagen Graf Einsiedel, Remo Kamm-Thonwart, Rahel Hoffmann, Yvonne Jäschke, Julia Martini, Florian Schepper

    Hintergrund. Krebserkrankungen bei Kindern sind mit einem erhöhten Risiko für psychosoziale Belastungen assoziiert. Zur quantitativen und qualitativen Bedarfseinschätzung nach psychosozialer Nachsorge liegen bisher keine Instrumente vor. Mit dem NPO-11 wurde nun ein ökonomisches Screening entwickelt. Patienten und Methoden. Elf dichotome Items erfassen die Bereiche Progredienzangst, Traurigkeit, Antrieblosigkeit, Selbstwertprobleme, Schul- und Ausbildungsprobleme, somatische Beschwerden, emotionaler Rückzug, soziale Desintegration, Pseudoreife, Eltern-Kind-Konflikte sowie Elternpaar-Konflikte entweder im Selbst- oder Elternbericht. Zur psychometrischen Überprüfung wurde der NPO-11 an N=101 Eltern-Kind-Dyaden getestet.Ergebnisse. Selbst- und Elternberichtversion zeigten eine gute Ausfüllgüte mit Zustimmungsraten ohne Boden- oder Deckeneffekte. Die Interrater-Reliabilität der 11 Items war ausreichend bis moderat. Faktorenanalytisch konnte die Gültigkeit eines Gesamtwerts nachgewiesen werden. Dieser zeigte für Selbst- und Elternbericht eine ausreichende bzw. gute interne Konsistenz sowie hohe Validität durch Korrelationen mit gesundheitsbezogener Lebensqualität.Schlussfolgerung. Mit dem NPO-11 wurde ein reliables und valides Screening zur Einschätzung des psychosozialen Nachsorgebedarfs in der pädiatrischen Onkologie entwickelt. Bei dem Übergang von stationärer zu ambulanter Behandlung kann eingeschätzt werden, welches Ausmaß an psychosozialen Interventionen notwendig ist und auf welche Themenfelder diese Angebote ausgerichtet sein sollten.